Sera Prognostics (SERA) Income towards Parent Company (2020 - 2026)
Sera Prognostics (SERA) reported Income towards Parent Company of -$8.4 million for Q1 2026, down 1.1% on a YoY basis from -$8.5 million in Q1 2025, and down 6.39% quarter-over-quarter from -$7.9 million in Q4 2025.
Sera Prognostics (SERA) Income towards Parent Company (2020 - 2026) Analysis & Trends
Sera Prognostics has reported Income towards Parent Company for 7 years, with the latest figure at -$8.4 million in Q1 2026.
- For the quarter ending Q1 2026, Income towards Parent Company fell 1.1% year-over-year to -$8.4 million; the trailing twelve-month figure through Mar 2026 stood at -$32.4 million (up 4.32% YoY), and the FY2025 full-year result was -$32.3 million, up 4.88% from the prior year.
- Income towards Parent Company for Q1 2026 stood at -$8.4 million, down from -$7.9 million in the prior quarter.
- The five-year high for Income towards Parent Company was -$7.7 million in Q3 2023, with the low at -$12.3 million in Q1 2022.
- Historically, Income towards Parent Company has averaged -$9.4 million across 5 years, with a median of -$8.4 million in 2024.
- Annual changes were most pronounced in 2022 — Income towards Parent Company slumped 94.31% — and 2023, when it jumped 31.09%.
- Sera Prognostics' Income towards Parent Company stood at -$10.4 million in 2022, then grew by 20.6% to -$8.3 million in 2023, then retreated by 5.67% to -$8.8 million in 2024, then climbed by 9.56% to -$7.9 million in 2025, then dropped by 6.39% to -$8.4 million in 2026.
- The last three Income towards Parent Company figures came in at -$8.4 million (Q1 2026), -$7.9 million (Q4 2025), and -$7.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Sera Prognostics | 100.52 Mn | 100.52 Mn | -28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.43 Mn |
| Dec 31, 2025 | -7.92 Mn |
| Sep 30, 2025 | -7.88 Mn |
| Jun 30, 2025 | -8.13 Mn |
| Mar 31, 2025 | -8.33 Mn |
| Dec 31, 2024 | -8.76 Mn |
| Sep 30, 2024 | -8.13 Mn |
| Jun 30, 2024 | -8.59 Mn |
| Mar 31, 2024 | -8.44 Mn |
| Dec 31, 2023 | -8.29 Mn |
| Sep 30, 2023 | -7.72 Mn |
| Jun 30, 2023 | -11.47 Mn |
| Mar 31, 2023 | -11.35 Mn |
| Dec 31, 2022 | -10.44 Mn |
| Sep 30, 2022 | -11.21 Mn |
| Jun 30, 2022 | -11.76 Mn |
| Mar 31, 2022 | -12.30 Mn |
| Dec 31, 2021 | -12.55 Mn |
| Sep 30, 2021 | -9.88 Mn |
| Jun 30, 2021 | -7.36 Mn |